Loading…
Zentalis Pharmaceuticals, Inc. is projected to rise to $5.51 by 2027, a +37% move from its current price of $4.02. ZNTL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.81 | $4.01 | $4.23 | -0.14% |
| May 30 | $3.73 | $4.01 | $4.31 | -0.28% |
| May 31 | $3.66 | $4.00 | $4.38 | -0.42% |
| Jun 1 | $3.60 | $4.00 | $4.43 | -0.56% |
| Jun 2 | $3.55 | $3.99 | $4.48 | -0.70% |
| Jun 3 | $3.51 | $3.99 | $4.53 | -0.84% |
| Jun 4 | $3.47 | $3.98 | $4.57 | -0.97% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.47 | $3.98 | $4.57 | -0.97% |
| Week 2 | $3.25 | $3.94 | $4.79 | -1.94% |
| Week 3 | $3.08 | $3.90 | $4.95 | -2.89% |
| Week 4 | $2.94 | $3.87 | $5.09 | -3.84% |
| Week 5 | $2.82 | $3.83 | $5.20 | -4.78% |
| Week 6 | $2.71 | $3.79 | $5.31 | -5.71% |
| Week 7 | $2.61 | $3.75 | $5.40 | -6.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types.
The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc.
was incorporated in 2014 and is based in San Diego, California.
The asset is Zentalis Pharmaceuticals, Inc. (ZNTL), a healthcare stock with a current price of $4.06.
Its market capitalization is $289.02M and it ranks 3563 in market cap.
The price outlook from the provided year-by-year forecast shows the 2026 average at $4.06 with ROI 0 and Neutral sentiment. In following years, the average price rises to $5.89 by 2030 (ROI 45) and to $10.71 by 2040 (ROI 163.7), with an average of $17.03 by 2050 (ROI 319.5).
A major floor 47.8% below — a decisive break under it would weaken the trend.
The nearest floor, 11.9% below — buyers have tended to step in here.
The nearest ceiling, 33.3% above — a clean break opens room to run.
A major ceiling 64.4% above — clearing it would confirm fresh momentum.
Key ZNTL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZNTL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.98 | Buy | $3.98 | Buy |
| MA 10 | $3.95 | Buy | $3.98 | Buy |
| MA 20 | $4.04 | Sell | $4.00 | Buy |
| MA 50 | $3.73 | Buy | $3.73 | Buy |
| MA 100 | $3.17 | Buy | $3.23 | Buy |
| MA 200 | $2.34 | Buy | $2.81 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.19 | Neutral |
| Stoch RSI (14) | 56.78 | Neutral |
| CCI (20) | -10.32 | Neutral |
| Williams %R (14) | -44.83 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -8.84 | Sell |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 55.17 | Neutral |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | -0.31 | Sell |
| Ultimate (7,14,28) | 46.75 | Neutral |
| Momentum (10) | -0.26 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 4.09 | Sell |
| ADX (14) | 9.02 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is bullish.
RSI14 is 50, and the stock trades above the SMA50 of $3.67 and the SMA200 of $2.31. Immediate support sits at $3.54 and resistance at $5.56, framing a 30-day range of $2.83 to $5.83. The stock exhibits higher volatility, with annualized volatility listed at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.37 | $4.02 | $6.09 | 0% | Neutral | |
| $3.98 | $5.51 | $8.23 | +37% | Bullish | |
| $4.05 | $5.93 | $9.41 | +47% | Bullish | |
| $3.79 | $5.83 | $9.69 | +45% | Bullish | |
| $3.70 | $5.95 | $10.27 | +48% | Bullish | |
| $3.17 | $5.31 | $9.49 | +32% | Bullish | |
| $3.14 | $5.49 | $10.09 | +36% | Bullish | |
| $4.09 | $7.42 | $14.02 | +85% | Bullish | |
| $4.49 | $8.46 | $16.37 | +110% | Bullish | |
| $4.64 | $9.07 | $17.95 | +126% | Bullish | |
| $4.95 | $11.00 | $23.88 | +174% | Bullish | |
| $8.00 | $17.77 | $40.87 | +342% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.37 | $4.02 | $4.75 | +0.00% |
| June 2026 | $3.08 | $3.68 | $4.57 | -8.34% |
| July 2026 | $2.91 | $3.54 | $4.50 | -3.96% |
| August 2026 | $3.08 | $3.80 | $4.92 | +7.35% |
| September 2026 | $3.12 | $3.88 | $5.11 | +2.24% |
| October 2026 | $3.02 | $3.80 | $5.07 | -2.04% |
| November 2026 | $3.21 | $4.08 | $5.51 | +7.32% |
| December 2026 | $3.49 | $4.47 | $6.09 | +9.38% |
Click any year to see its month-by-month ZNTL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ZNTL could reach as high as $6.09, with a base case around $4.02 and support toward $1.37 — roughly 0% from $4.02. A consolidation phase looks the most probable path here.
Expect ZNTL to range from $3.98 to $8.23 through 2027. The $5.51 average target implies a +37% move from current prices. That is up +37% on the projected 2026 average. Momentum favours further upside here.
The ZNTL price prediction for 2028 points to an average of $5.93 (low $4.05, high $9.41) — a potential gain of +47% on today's $4.02. Buyers look set to stay in control over this stretch.
In 2029, ZNTL is projected to trade between $3.79 and $9.69, averaging $5.83 — a potential gain of +45% from today's $4.02. That is -2% versus the projected 2028 average. Momentum favours further upside here.
Zentalis Pharmaceuticals, Inc.'s 2030 outlook centres on $5.95, within a $3.70 to $10.27 range. That is up +2% on the projected 2029 average. That marks a +48% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ZNTL could reach as high as $9.49, with a base case around $5.31 and support toward $3.17 — roughly +32% from $4.02. Momentum favours further upside here.
Expect ZNTL to range from $3.14 to $10.09 through 2032. The $5.49 average target implies a +36% move from current prices. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ZNTL price prediction for 2033 points to an average of $7.42 (low $4.09, high $14.02) — a potential gain of +85% on today's $4.02. Momentum favours further upside here.
In 2034, ZNTL is projected to trade between $4.49 and $16.37, averaging $8.46 — a potential gain of +110% from today's $4.02. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Zentalis Pharmaceuticals, Inc.'s 2035 outlook centres on $9.07, within a $4.64 to $17.95 range. That is up +7% on the projected 2034 average. That marks a +126% change versus current levels. Momentum favours further upside here.
By 2040, ZNTL could reach as high as $23.88, with a base case around $11.00 and support toward $4.95 — roughly +174% from $4.02. Buyers look set to stay in control over this stretch.
Expect ZNTL to range from $8.00 to $40.87 through 2050. The $17.77 average target implies a +342% move from current prices. That is up +62% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ZNTL today (≈ 248.756219 ZNTL) could be worth
$4,420.52
+$3,420.52 (+342%) by 2050 · US Dollar
Based on the average projected ZNTL price of $17.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZNTLwould be worth at today's price.
$1,000 invested in ZNTL on May 27, 2025 (≈ 833.3333 ZNTL) would be worth
$3,350
+$2,350 (+235.0%) today · 3.35× · US Dollar
Based on a ZNTL entry price of $1.2 vs. today's $4.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.71 | $1,083.56 | +8.4% |
| 1 month ago | $4.25 | $945.88 | -5.4% |
| 3 months ago | $2.47 | $1,627.53 | +62.8% |
| 6 months ago | $1.43 | $2,811.19 | +181.1% |
| 1 year ago | $1.2 | $3,350 | +235.0% |
| All time (5.0y) ago | $53.53 | $75.1 | -92.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZNTL forecast.
Our base-case forecast reaches $8.00 around 2034.
Implied market cap at $8.00: $569.49M
The multi-year outlook shows a bullish trajectory with meaningful upside across years. By 2030 the average forecast price is $5.89 with a corresponding ROI of 45 and bullish sentiment. By 2040 the average forecast rises to $10.71 with a ROI of 163.7 and bullish sentiment, and by 2050 the average forecast reaches $17.03 with a ROI of 319.5 and bullish sentiment.
These figures imply substantial upside from the current level, especially in the 2030–2050 window. The 2026 forecast remains at the current level with an average of $4.06 and ROI of 0, reflecting a flat near-term path before higher targets emerge later.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $5.89, with a min of $3.62 and a max of $10.27, and an ROI of 45. Sentiment is BULLISH.
Forecasts include multiple bullish years (for example 2027, 2028, 2029 and beyond) and a long-term upside with an average in 2050 of $17.03 and ROI of 319.5, but these are estimates, not guarantees.
Yes. The 2030 max is $10.27, and higher maxima occur in later years (2033 max $13.81; 2034 max $16.51; 2040 max $23.56; 2050 max $39.18).
Current price is $4.06 and market capitalization is $289.02M.
The 30-day range runs from $2.83 to $5.83.
Zentalis Pharmaceuticals, Inc. Community Discussion
0Share your Zentalis Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.